Founded in 2019 or earlier, Lavo Life Sciences is a venture capital-backed startup focused on creating innovative software solutions for drug development. Their platform leverages artificial intelligence to enhance crystal structure predictions for small molecule pharmaceuticals, effectively minimizing risks in development pipelines, refining solid-state formulations, and preventing unexpected challenges in later stages. The Crystal Console, their online tool, offers advanced capabilities for analyzing crystal structures, conducting virtual polymorph screenings, and performing PXRD analyses.
Research & Insights

.png)

